Skip to content

Advertisement

  • Correction
  • Open Access

Correction to: The mTOR inhibitor rapamycin down-regulates the expression of the ubiquitin ligase subunit Skp2 in breast cancer cells

  • 1, 2,
  • 3,
  • 2 and
  • 1, 2, 4Email author
Breast Cancer Research201820:68

https://doi.org/10.1186/s13058-018-1000-4

  • Received: 29 May 2018
  • Accepted: 29 May 2018
  • Published:

The original article was published in Breast Cancer Research 2006 8:R46

Correction

After the publication of this work [1], an error was noticed in Fig. 2b, Fig. 3a and Fig. 5b. The Skp1 loading control was accidentally duplicated. We apologize for this error, which did not affect any of the interpretations or conclusions of the article.

Notes

Declarations

Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.

Authors’ Affiliations

(1)
Department of Surgery A, Rambam Medical Center, 31096 Haifa, Israel
(2)
Technion – Israel Institute of Technology, 31096 Haifa, Israel
(3)
Department of Surgery B, Rambam Medical Center, 31096 Haifa, Israel
(4)
Breast Health Institute, Rambam Medical Center, 31096 Haifa, Israel

Reference

  1. Hershko D, et al. The mTOR inhibitor rapamycin down-regulates the expression of the ubiquitin ligase subunit Skp2 in breast cancer cells. Breast Cancer Res. 2006;8(4):R46.View ArticlePubMedPubMed CentralGoogle Scholar

Copyright

© The Author(s). 2018

Advertisement